BPC-157

BPC-157 — Body Protection Compound / Repair & Recovery Peptide

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide originally isolated from a protective protein found in human stomach juice. Researchers noticed the parent protein helped the gut lining survive acid and injury, and when they synthesized this fragment of it, the effects extended well beyond the stomach – BPC-157 peptide research now spans tendon and ligament healing, muscle recovery, gut inflammation, and blood vessel formation. That range is what makes it one of the most-studied peptides in regenerative biology.

Why BPC-157’s Broad Activity Matters

Most peptides hit one receptor and do one thing. BPC-157 doesn’t – it nudges several repair pathways at once, which is why it is interesting for research models where more than one system has to come back online at the same time (like a tendon tear, where you need new blood vessels, new cells migrating in, and new connective tissue all together).

One practical quirk: because BPC-157 started life in the stomach, it is unusually stable in acid. That is why it is one of the few peptides in this class studied both as an injection and as an oral preparation.

BPC-157 vs TB-500 — Why Researchers Pair Them

BPC-157 and TB-500 (Thymosin Beta-4 fragment) are the two most commonly paired peptides in soft-tissue repair research. They don’t overlap much – each one owns a different part of the repair process, which is why the BPC-157 / TB-500 stack is a standard combination in the published literature.

Forschungsanwendungen

BPC-157 is used in studies examining:

• Tendon, ligament, and muscle repair after acute or chronic injury
• Gastric and intestinal lining recovery in ulcer and IBD models
• New blood vessel formation after a vessel has been blocked
• Bone and cartilage healing in fracture models
• Neuroprotection in stroke and spinal cord injury models
• Oral vs. injectable bioavailability comparisons
• Combination protocols with TB-500 for soft-tissue repair

Technische Daten

Rekonstitution

BPC-157 arrives as a freeze-dried powder and has to be mixed with bacteriostatic water before use. The math is simple:

Gesamtmenge in mg im Fläschchen ÷ hinzugefügte Wassermenge in ml = mg pro ml

Beispiel: eine 5-mg-Ampulle + 2 ml bakteriostatisches Wasser = 2,5 mg pro ml.

Nach der Zubereitung bei 2–8 °C lagern und innerhalb von 28–30 Tagen verbrauchen.

Anmerkungen zum Protokoll

The following values are reference points extracted from published BPC-157 research – not instructions. Preclinical studies report activity across a surprisingly wide range, with effects noted at both microgram and milligram levels. Its short plasma half-life (under about 30 minutes) is why most protocols in the literature split the daily amount into two administrations or use local injection near the target tissue.

• Dose ranges reported in the literature: 200-500mcg per administration
• Verabreichungshäufigkeit in veröffentlichten Studien: Ein- bis zweimal täglich
• Routes studied: Subcutaneous, intramuscular, intraperitoneal, oral
• Study durations reported: 2-8 weeks depending on tissue type

Common Questions About BPC-157 Research

What does BPC-157 do in research models?

Published studies report BPC-157 activity on blood vessel formation (angiogenesis), cell migration at wound sites, growth factor gene expression, and gut-brain neurotransmitter signaling. It is studied across tendon and ligament healing, gastric ulcer models, muscle recovery, and neuroprotection. It is a pleiotropic peptide – it engages several pathways at once rather than one receptor.

What are the reported side effects of BPC-157 in research?

In the preclinical toxicology literature, no minimum toxic dose or lethal dose has been established, and no genotoxic, teratogenic, or anaphylactic effects have been reported in animal models. The most commonly noted observations are mild injection-site irritation and, in limited human pilot data, transient nausea at higher doses. BPC-157 is not FDA approved and is sold strictly for research use only.

How does BPC-157 compare to TB-500 for tissue repair research?

BPC-157 and TB-500 (Thymosin Beta-4 fragment) don’t overlap much. BPC-157 is primarily local – it drives new blood vessels and growth factor expression at the injury site. TB-500 is primarily systemic – it regulates actin in cells throughout the body and moves cells into the wound. They are routinely paired in soft-tissue repair research because they cover different parts of the same healing process.

Is BPC-157 FDA approved?

No. BPC-157 is not approved by the FDA for any use and is listed by the World Anti-Doping Agency (WADA) as prohibited in competitive sport. Every vial WWP ships is sold strictly for laboratory and research use only, not for human consumption.

How is BPC-157 stored?

Ungeöffnete Fläschchen werden bei 2–8 °C (Kühlschranktemperatur) gelagert und sind mindestens 12 Monate lang haltbar. Nach der Rekonstitution mit bakteriostatischem Wasser wird die Lösung bei 2–8 °C aufbewahrt und innerhalb von 28–30 Tagen verbraucht.

Forschungsstapel

BPC-157 is commonly paired in research settings with:

• TB-500 – BPC-157 drives new blood vessels and growth factor activity at the injury; TB-500 handles cell migration and systemic anti-inflammatory effects. The two are the classic soft-tissue repair pairing.
• GHK-Cu – GHK-Cu stimulates collagen and matrix rebuilding. Pairing it with BPC-157 lets researchers look at the full arc – repair signaling plus structural rebuild.
• KPV – KPV is a small anti-inflammatory peptide active at mucosal surfaces. Frequently paired with BPC-157 in gut-focused research.

Reinheitsgarantie

Jede Charge weist eine Reinheit von ≥99 % auf. Senden Sie uns ein Analysezertifikat einer unabhängigen Prüfstelle, und wir stellen Ihnen unabhängig vom Ergebnis eine Gutschrift aus.